PD-1 knockout engineered T cells
/ Anhui Kedgene Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 13, 2019
PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer
(clinicaltrials.gov)
- P=N/A; N=16; Completed; Sponsor: Hangzhou Cancer Hospital; Recruiting ➔ Completed; Phase classification: P2 ➔ PN/A
Clinical • Phase classification • Trial completion
1 to 1
Of
1
Go to page
1